AKTS 10-Q: SEC filing
Aktis Oncology
Filed with the SEC on · accession 0001193125-26-457054
AKTS filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. Aktis Oncology filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing financial results including a net loss and research and development expenses. The stock moved -1.3% by the first close after the filing.
Summary of the filing
Aktis Oncology filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing financial results including a net loss and research and development expenses. The filing also references an IPO completed in January 2026 and a collaboration agreement with Eli Lilly.
Key details
How AKTS stock reacted
Close before
$17.04
Nov 11, 2026
First close after
-1.29%
$16.82
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for AKTS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for AKTS?
Click hereFrequently asked questions
What did AKTS file with the SEC on Nov 12, 2026?
AKTS filed a 10-Q (SEC filing). Aktis Oncology filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing financial results including a net loss and research and development expenses. The filing also references an IPO completed in January 2026 and a collaboration agreement with Eli Lilly.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did AKTS stock react to this filing?
AKTS closed at $17.04 before the filing and $16.82 on Nov 12, 2026 (-1.29%).
Other AKTS SEC filings
Get alerts when AKTS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days